Affini-T Therapeutics’ $175 Million Financing

Latham & Watkins and Wilson Sonsini represented Affini-T Therapeutics, Inc. in the transaction.Affini-T Therapeutics, Inc., a biotechnology company unlocking the power of T cells against oncogenic driver…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now